Inside informationEnglish
Press Release: Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 12/01/2026, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 118645_20260112